Microbix Biosystems
Manufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
265 Watline Ave, Mississauga, Ontario, L...Phone Number
(905) 361-8910Website
www.microbix.comRevenue
$13.4 MillionStock Symbol
MBXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Microbix Biosystems
Microbix, founded in 1988, develops proprietary biological and technology solutions for human health and well-being. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Microbix also applies its biological expertise and infrastructure to develop other proprietary products and technologies, most notably Kinlytic® urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix is publicly-traded on the TSX and OTCQB, and headquartered in Mississauga, Ontario, Canada.Explore more
Microbix Biosystems Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Microbix Biosystems your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Microbix Biosystems, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Microbix Biosystems
Click to see if Microbix Biosystems had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Microbix Biosystems launches new products
Check if Microbix Biosystems has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Microbix Biosystems recently announced quarterly report
Check out if Microbix Biosystems is spiking on competitors!
Funding: Get notified immidiatlly once Microbix Biosystems has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Microbix Biosystems
Compare insights from companies similar to Microbix Biosystems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Microbix Biosystems is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Microbix Biosystems is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Microbix Biosystems.
Microbix Biosystems financials insights
Gather financial insights about Microbix Biosystems, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$2.3M
Microbix Biosystems Tech Stack
A closer look at the technologies used by Microbix Biosystems
See more technologies
Most Recent Scoops
Pain Point
experienced a cybersecurity breach on a legacy server that was recovered from backups within a couple of days with no operational disruptions.
Project
Microbix Biosystems has announced that its Kinlytic partner and its private equity backers are providing full project funding, with the company participating through potential non-recurring milestones totaling up to USD 31 million plus double-digit recurring royalties on all revenues from all applications and markets, starting with the catheter clearance indication in the United States.
Governmental Affairs & Regulation, Business Finance, Finance, Regulations, Risk
Project
Microbix Biosystems is working with Seqens to update Kinlytic production processes to contemporary standards at the U.S. FDA's request, including reducing animal components and increasing testing veracity, with the relationship progressing excellently.
Governmental Affairs & Regulation, Business Finance, Finance, Regulations, Risk
Project
Microbix Biosystems has established multiple new program and product collaborations with proficiency testing and external quality assessment scheme providers in infectious diseases, oncology, molecular pathology, and genetics testing, expanding its addressable markets beyond traditional infectious disease strengths.
Governmental Affairs & Regulation, Business Finance, Finance, Regulations, Risk
Product Launch
Product Launch
Microbix Biosystems News & Media
Microbix Biosystems Inc. (MBX:CA) Shareholder/Analyst Call Transcript
Microbix Biosystems Inc. (MBX:CA) Shareholder/Analyst Call March 25, 2026 1:00 PM EDTCompany ParticipantsChristopher Lobb - Compliance Officer, General...Microbix Biosystems Inc. (MBX:CA) Q1 2026 Earnings Call Transcript
Microbix Biosystems Inc. (MBX:CA) Q1 2026 Earnings Call February 12, 2026 10:00 AM ESTCompany ParticipantsCameron Groome - President, CEO &...Microbix Biosystems Inc (MBXBF) Q4 2025 Earnings Call Highlights: Navigating Challenges and ...
Despite a revenue decline, Microbix Biosystems Inc (MBXBF) focuses on strategic investments and product expansion to drive future growth.Microbix Biosystems Inc. (MBX:CA) Q4 2025 Earnings Call Transcript
Microbix Biosystems Inc. (MBX:CA) Q4 2025 Earnings Call December 18, 2025 10:00 AM ESTCompany ParticipantsCameron Groome - President, CEO &...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Microbix Biosystems
Sign Up For FreeTo access detailed company insights
Microbix, founded in 1988, develops proprietary biological and technology solutions for human health and well-being. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable... Read More
